Active ingredient
Sildenafil citrate 100 mg — the same as Kamagra
Content and sources reviewed
The women's version
Lovegra is Ajanta Pharma's sildenafil tablet marketed for women — the pink-packaged sibling of Kamagra. It is the only 'female' product in the Ajanta line, and it deserves an honest conversation about what the evidence does and does not show.

Lovegra is sildenafil citrate 100 mg — the identical active ingredient as Kamagra and Viagra — packaged and marketed toward women for low sexual desire and arousal difficulties.
The honest part: sildenafil is not approved for women by the FDA, the EMA, or most national regulators, and the trial evidence in women is genuinely mixed. What the research does suggest is that PDE5 inhibitors help a subgroup of women — most clearly those whose sexual difficulties are tied to antidepressants (SSRI-related) or to physiological arousal problems — rather than low desire on its own. Lovegra is therefore an off-label product: it may be discussed in some markets, but it has no regulatory stamp of approval for female use.
The essentials — and the caveats — in one place.
Sildenafil citrate 100 mg — the same as Kamagra
Ajanta Pharma (India)
Female sexual arousal difficulties and low libido
Off-label — not approved for women by the FDA or EMA
Mixed; clearest benefit in SSRI-related and arousal-type difficulties
Pregnancy or breastfeeding — no adequate safety data
In marketing, yes — it is sildenafil aimed at women. In regulatory terms, no: no sildenafil product is approved for female sexual dysfunction by major regulators, and the trial evidence is mixed.
Mechanically, it increases blood flow to the genital area. Whether that translates into meaningful benefit depends on the cause of the difficulty — which is exactly why an assessment matters first.
No — it is unregistered with HSA and sildenafil is prescription-only, so local sale is illegal. Nor would a prescription help: sildenafil is not approved for women in any major market.
Women who are pregnant or breastfeeding, anyone taking nitrates, and anyone with the standard sildenafil cautions. A prescriber must assess suitability.
Yes — 100 mg of the same sildenafil. The difference is branding and marketing, not chemistry.
Singapore's national patient information on sildenafil — written for its approved use in men.
Why unregistered products marketed at women carry the same quality risks.
The evidence behind the medicine that is actually approved for low desire in premenopausal women.
The link below is an affiliate link to a third-party seller. Lovegra is an off-label, unregistered product for women — an assessment with a clinician is the step the evidence supports first.